News & Insights

120 News Results
January 17, 2023
Commentary by Jason S. Kanterman

The U.S. Supreme Court agreed to consider a pair of whistleblower-initiated False Claims Act cases accusing two pharmacy operators of billing Medicare and Medicaid programs for prescription drugs at artificially high rates while charging non-governmentally insured customers lesser prices for those same drugs.